Skip to Content

Valeant Stake Continues to Cost Sequoia

Continued controversy with top-holding Valeant has dragged down long-term returns and led to outflows at this venerable fund.

Securities In This Article
Sequoia
(SEQUX)
Bausch Health Companies Inc
(BHC)

We have placed the Morningstar Analyst Rating for

Top-holding

As Valeant's largest shareholder, this fund has been hit hard on a number of fronts. With Valeant's shares down more than 70% since mid-September, the fund's once-exceptional trailing results are in tatters going back 10 years. The damage has been so severe because the Valeant position was 28.7% of assets in June 2015 before the share price started falling last August.

Exiting shareholders have put further pressure on the fund by pulling out nearly $800 million over the six months through February 2016. Given that the fund held just 5.2% of assets in cash as of year-end 2015, which was low by historical standards, managers Bob Goldfarb and David Poppe have likely been selling shares to meet redemptions. Valeant's crash could accelerate outflows in March. This could then lead to a hefty capital gains distribution for remaining shareholders.

These events also raise questions about the fund itself. Goldfarb, Poppe, and their team of analysts have long been known for their in-depth knowledge of their holdings. We don't doubt their efforts to understand Valeant's challenges, but the fund's process should be re-evaluated. Specifically, the team does not seem to have taken any steps to mitigate the risks of such a large position. In fact, they bought additional shares in 2015's fourth quarter, which famously led to the resignation of two board members. Because of these concerns, we have placed this fund under review.

Morningstar Premium Members gain exclusive access to our full Sequoia report, including ratings across all five Morningstar Pillars. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

More in Funds

About the Author

Kevin McDevitt

Senior Analyst
More from Author

Kevin McDevitt, CFA, is a senior manager research analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. He covers primarily domestic- and international-equity strategies, as well as some multi-asset strategies.

Before rejoining Morningstar in 2009, McDevitt was an associate equity analyst and later managed trust portfolios for AG Edwards, which became Wachovia (now Wells Fargo). McDevitt originally joined Morningstar in 1995. He was a mutual fund analyst from 1996 to 1999 and also held positions within the company’s international team, Morningstar Associates, and Morningstar Investment Services.

McDevitt holds a bachelor’s degree in finance from the College of William & Mary and a master’s degree in business administration from Washington University. He also holds the Chartered Financial Analyst® designation.

Sponsor Center